The outlook for technology-enabled personalized care in healthcare and life sciences

Over the next five years, healthcare and life sciences organizations will navigate unique disruptive forces presented by a digital world that will shape many aspects of the industry landscape, from value-based care to therapies. prescription digital. A report from IDC Research, a leading global market research firm, offers predictions on how organizations can navigate the winds of change, impacting technologies to adopt, capabilities to to move forward and the partnerships to pursue.

The conclusions of the report, IDC FutureScape: Global Healthcare Industry Forecast 2022will be featured in an upcoming webinar sponsored by Twilio. The webinar is scheduled for June 7 from 3:30-4:30 p.m. ET, 12:30-1:30 p.m. PT.

In the discussion between Mutaz Shegewi, Director of Research at IDC, Dr. Nimita Limaye, Vice President of Research at IDC, and Susan Lucas Collins, Global Head of Health Services at Twilioregistrants will learn more about:

  • Recent Global Health Industry Predictions for 2022 Advance Healthcare and Life Sciences Organizations in a Digitally Driven World
  • The role innovative and disruptive technologies will play in helping healthcare become more connected and personalized
  • Key business and IT considerations for organizations as the industry continues to digitally transform

Twilio is the leading platform for driving customer engagement across marketing, services, and operations. With a single programmable platform, marketers can optimize communications across any channel, developers can create differentiated customer experiences, and businesses can develop lasting relationships with their customers. Twilio is headquartered in San Francisco with offices around the world.

Here is an overview of the webinar speakers:

Susan Lucas Collins, Global Head of Healthcare, Twilio

Susan Collins is a globally recognized expert in health technology and go-to-market strategy, speaking regularly at conferences and providing thought leadership to a variety of professional journals and media.

Currently Global Head of Healthcare for Twilio, Collins leads the company’s healthcare vertical and has established Twilio as the leading communications and engagement technology provider for iconic brands such as Epic, ZocDoc, Doximity, Doctor On Demand and MDLive as well as many hospitals and healthcare systems. , public health agencies and life science organizations.

Previously, she led innovation and healthcare business units at Salesforce, advising the company’s largest clients on digital transformation and securing partnership deals with leading healthcare technology companies. She also launched the Enterprise Health Clouds category, now leveraged by analysts who track the healthcare CRM space.

Collins has also led organizations within the Yale New Haven and Emory Healthcare systems as Director of Marketing and Customer Services for Advanced Radiology and CEO of Atlanta Radiology respectively.

Mutaz Shegewi, Research Director, Vendor IT Transformation Strategies, IDC Research

Mutaz Shegewi leads the provider research practice at IDC Health Insights. It covers the topics most relevant to healthcare provider organizations looking to digitally transform and become more digital natives than their competitors. Mutaz advises the executive, clinical and technical management of the world’s leading providers and buyers of health information technology. He produces data-driven research and thought leadership insights that help address strategic health information technology challenges and transform complexity into clarity in decision-making that would reduce costs, improve quality , optimize access, improve patient safety and champion the patient experience. Mutaz is passionate about strengthening health systems through the dynamic interrelationships between technology, patients and providers by combining industrial, professional, academic, technical and global expertise in health, policy, business , management, research, consulting and medicine.

Dr. Nimita Limaye, Vice President of Research, IDC Health Insights

Dr. Nimita Limaye is Vice President of Research at IDC Health Insights and provides research-based consulting and advisory services, as well as market analysis on key topics related to R&D strategy and technology in the life sciences industry. She discusses aspects such as the role of digital transformation in discovery research, e-clinical ecosystems, the role of NLP, AI, ML, DL, RPA, in transforming drug development , precision medicine, pharmaceutical R&D execution and strategic outsourcing models.

Nimita is an executive business leader with over two decades of life science leadership experience in the pharmaceutical/CRO/life science and technology consulting industry. Passionate about the role of data, technology and analytics in transforming clinical trials and paving the way for the trials of the future. She also serves as a mentor for the start-ups of the Mass Bio Digital Health initiative.

Nimita holds a PhD in biotechnology and has chaired the board of industry associations such as SCDM. She is actively associated with the DIA and AMWA. She has chaired several conferences, led industry roundtables, given keynote speeches, led webinars, and authored over 40 publications/white papers. Her main focus has been on the role of technology in transforming drug development, virtual clinical trials, patient-centered clinical trials, the use of social media in drug development, data-based monitoring risks and precision medicine.

Image: Elenabs, Getty Images

To register for the June 7 webinar, please complete the form below.

Comments are closed.